logo

Sorrento Therapeutics, Inc. (SRNE)



Trade SRNE now with
  Date
  Headline
1/10/2020 7:04:44 AM Sorrento Therapeutics Gets Non-binding Proposal From A Private Equity Fund To Buy Shares Of The Company For Up To $7/Shr
1/6/2020 7:12:46 AM Sorrento: Mabpharm File NDA For Infliximab Biosimilar Antibody In China
12/16/2019 7:19:52 AM Sorrento Therapeutics Adds Robin Smith To Its Board
11/25/2019 7:05:01 AM Sorrento Therapeutics Reports Receipt Of Acquisition Proposal; Rejects Offer
10/15/2019 11:02:10 PM Los Angeles Court Rejects Patrick Soon-Shiong Attempt To Avoid Sorrento Litigation
10/9/2019 10:48:31 AM Sorrento Therapeutics Closes $25 Mln Registered Direct Offering
10/7/2019 2:36:17 PM Sorrento Therapeutics Announces $25 Mln Registered Direct Offering
6/28/2019 8:40:28 AM Sorrento Therapeutics Prices Public Offering Of Common Stock, Warrants
6/28/2019 6:03:45 AM Sorrento Therapeutics Intends To Offer Common Shares, Warrants
6/19/2019 7:06:23 AM Sorrento Therapeutics Updates Positive Results Of Phase 1b Resiniferatoxin In Knee Osteoarthritis Pain Trial
6/12/2019 7:12:04 AM Sorrento To Explore Potential IPO Of Scilex Holding Company
6/12/2019 7:03:17 AM Sorrento Therapeutics Explores Possibility Of IPO Of Scilex Holding
6/4/2019 7:06:32 AM Sorrento Announces CBD Global JVs, Commercial Strategic Partnerships
3/22/2019 7:05:40 AM Sorrento Therapeutics Announces Merger Of Scilex And Semnur
1/22/2019 7:07:19 AM Sorrento Therapeutics Announces Interim Results In Osteoarthritis Knee Pain Phase 1b Trial Of Resiniferatoxin
1/14/2019 7:09:42 AM Scilex Reports Addition Of ZTlido To Express Scripts National Formularies
  
 
>